Key result
The selective PKC inhibitor Ro 31-7549 had no effect on AT1 receptor desensitisation but caused a dose-dependent reduction in calcium release from intracellular stores.
In CHO cells expressing human AT1 receptors, PKC inhibition reduces intracellular calcium release but does not affect receptor desensitisation, suggesting PKC acts distally to the receptor.
Answers are grounded in this paper and cite their sources.
PKC inhibition may act distally to AT1 receptors in calcium signaling; leaves open any role in desensitization or clinical relevance.
The mechanism underlying type I angiotensin II (Ang II) receptor (AT1 receptor) desensitisation is unknown. Structural features suggest it may be a substrate for protein kinase C (PKC). The effects of a selective PKC inhibitor, Ro 31-7549, on receptor desensitisation were investigated in CHO cells expressing the human AT1 receptor. Desensitisation was demonstrated with respect to the calcium response to Ang II in Fura-2-loaded cells. Ro 31-7549 had no effect on desensitisation. However, pretreatment with Ro 31-7549 caused a dose-dependent reduction in calcium release from intracellular stores. PKC may therefore act at a locus distal from the receptor itself.
No takes yet. Share an insight, caveat, or question.
Barker et al. (1995) studied this question. Ro 31-7549 was evaluated on Receptor desensitisation and intracellular calcium release. The selective PKC inhibitor Ro 31-7549 had no effect on AT1 receptor desensitisation but caused a dose-dependent reduction in calcium release from intracellular stores.
Synapse has enriched 10 related papers. Consider them for comparative context: